Global Organ Preservation Solution Market

Organ Preservation Solution Market Overview: Market Size, Major Drivers And Trends

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032


As we delve into the intricate landscape of the organ preservation solution market, a sector vital for advancing healthcare through organ transplantation, it’s evident that the market is on a trajectory of significant growth. With projections indicating an increase from $255.35 billion in 2022 to $274.48 billion in 2023, marking a compound annual growth rate (CAGR) of 7.49%, the market is poised for substantial expansion, reaching $371.53 billion by 2027 with a CAGR of 7.86%.


**1. Paving the Way: Rise in Organ Transplantation

The escalating prominence of organ transplantation emerges as a key driver propelling the organ preservation solution market. This medical procedure involves the extraction and transfer of organs or tissues from a donor to a recipient, showcasing the critical role preservation solutions play in reducing organ damage during transportation and storage. Notably, statistics from the Organ Procurement and Transplantation Network (OPTN) highlight a 3.7% increase in organ transplants in 2022, with a significant portion dedicated to kidney transplants.

  • Organ transplantation gains prominence in healthcare
  • Organ preservation solutions reduce organ damage during transportation and storage
  • 42,887 organ transplants conducted in 2022, demonstrating a 3.7% increase


**2. Industry Leaders: Navigating Market Dynamics

The organ preservation solution market is influenced by key players steering the industry’s trajectory. Bristol-Myers Squibb Company, Baxter International Inc., and Teva Pharmaceutical Industries Ltd. are among the major players contributing to the market’s growth and shaping its future.

  • Major players include Bristol-Myers Squibb Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd.
  • Industry leaders play a pivotal role in driving market dynamics


**3. Innovative Solutions: Driving Market Trends

Product innovation emerges as a defining trend in the organ preservation solution market, with companies focusing on developing cutting-edge products to fortify their positions. Paragonix Technologies Inc.’s launch of the LIVERguard Donor Liver Preservation System in October 2021 stands as a testament to this trend, offering advanced settings for hypothermic liver preservation with real-time digital monitoring.

  • Product innovation gains traction in the market
  • Paragonix Technologies Inc. launches LIVERguard for advanced liver preservation
  • Real-time digital monitoring ensures donor liver protection throughout the transplant process


**4. Segmentation Insights: Navigating Diversity

The organ preservation solution market exhibits intricate segmentation, reflecting diverse solution types, organ types, and techniques.

– Solution Type:

  1. Viaspan
  2. Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate)
  3. Renograf
  4. Hypothermosol
  5. Perfadex
  6. Lifor
  7. HBS (Hyperosmotic Blood Substitute) Solution
  8. siRNA (Small Interfering RNA) Transplant Solutions
  9. Other Solution Types

– Organ Type:

  1. Kidneys
  2. Liver
  3. Lung
  4. Heart
  5. Other Organ Types

– Technique:

  1. Static Cold Storage (SCS) Technique
  2. Hypothermic Machine Perfusion
  3. Other Techniques


**5. Regional Dynamics: North America Leads, Asia-Pacific Soars

In 2022, North America takes the lead as the largest region in the organ preservation solution market, showcasing the region’s robust healthcare infrastructure. Looking ahead, Asia-Pacific is poised to be the fastest-growing region, reflecting the region’s increasing focus on healthcare advancements.

  • North America leads as the largest region in the market in 2022
  • Asia-Pacific projected to be the fastest-growing region


**6. Charting the Trajectory: Future Growth to $371.53 Billion by 2027

As we navigate the intricate landscape of the organ preservation solution market, projections indicate a robust future. By 2027, the market is anticipated to reach $371.53 billion, underlining its pivotal role in advancing healthcare through innovative solutions, transformative medical procedures, and an unwavering commitment to saving lives.


Get A Free Sample On The Global Organ Preservation Solution Market Report:


Read The Full Organ Preservation Solution Market Report Here:


The Organ Preservation Solution Global Market Report 2023  provides an overview of the organ preservation solution market for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The organ preservation solution market forecast analyzes organ preservation solution market size, organ preservation solution market share, leading competitor and their market positions.


Explore Similar Reports From The Business Research Company:

Artificial Organ Global Market Report 2023

Artificial Organ And Bionics Global Market Report 2023

Organ Transplant Immunosuppressant Drugs Global Market Report 2023


Learn More About The Business Research Company
The Business Research Company has published over 6500+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.


Contact us at:
The Business Research Company:
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at


Follow us on:
Global Market Model:
Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *